Allicin enhances chemotherapeutic response and ameliorates tamoxifen-induced liver injury in experimental animals

Pharmaceutical Biology

Volumn 52, Issue 8, 2014, Pages 1009-1014

  Suddek, Ghada M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Antioxidant; Antitumor; Murine tumor; Thiosulfinate molecule

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALLICIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; TAMOXIFEN CITRATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ANTIOXIDANT; SULFINIC ACID DERIVATIVE; TAMOXIFEN;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; EHRLICH ASCITES TUMOR CELL; FEMALE; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER INJURY; LIVER PROTECTION; NONHUMAN; TUMOR VOLUME; ANIMAL; CARCINOMA, EHRLICH TUMOR; DRUG SCREENING; DRUG-INDUCED LIVER INJURY; METABOLISM; MOUSE; PROCEDURES; RANDOMIZATION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTIOXIDANTS; CARCINOMA, EHRLICH TUMOR; DRUG-INDUCED LIVER INJURY; FEMALE; MICE; RANDOM ALLOCATION; RATS; SULFINIC ACIDS; TAMOXIFEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904118754     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.876053     Document Type: Article

References (35)

1. Al-Akoum M, Dodin S, Akoum A. (2007). Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: An in vitro study. Can J Physiol Pharmacol 85: 1153-9.
2. Albukhari AA, Gashlan HM, El-Beshbishy HA, et al. (2009). Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats. Food Chem Toxicol 47:1689-95.
3. Ahotupa M, Hirsimaki P, Parssinen R, Mantyla E. (1994). Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in rats. Carcinogenesis 15:863-8.
4. Badary OA, Sharaby SA, Kenawy SA, et al. (2000). Evaluation of cisplatin combined with ondansetron in Ehrlich ascites carcinoma in vitro and in vivo. Tumori 86:153-6.
5. Bhatia A, Singh B, Bhushan S, Katare OP. (2010). Tamoxifenencapsulated vesicular systems: Cytotoxicity evaluation in human epidermal keratinocyte cell line. Drug Dev Ind Pharm 36:350-4.
6. Caballero F, Gerez E, Oliveri L, et al. (2001). On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p- dimethylaminobenzene in CF1 mice. Int J Biochem Cell Biol 33: 681-90.
7. Chan JY, Yuen AC, Chan RY, Chan SW. (2013). A review of the cardiovascular benefits and antioxidant properties of allicin. Phytother Res 27:637-46.
8. Chu ST, Huang CC, Huang CJ, et al. (2007). Tamoxifen-induced [Ca2+]i rises and Ca2+-independent cell death in human oral cancer cells. J Recept Signal Transduct Res 27:353-67.
9. Daniel WW. (1991). Hypothesis testing. In: Biostatistics: A Foundation for Analysis in the Health Sciences, 5th ed. New York, Chichester, Brisbane, Toronto, Singapore: John Wiley & Sons, 191.
10. Desai PB, Nallani SC, Sane RS, et al. (2002). Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen. Drug Metab Dispos 30:608-12.
11. Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-7.
12. El-Beshbishy HA. (2007). Lipoic acid attenuates DNA fragmentation, oxidative stress and liver injury induced by tamoxifen in rats. Asian J Trad Med 2:175-88.
13. El-Beshbishy HA, Mohamadin AM, Nagy AA, Abdel-Naim AB. (2010). Amelioration of tamoxifen-induced liver injury in rats by grape seed extract, black seed extract and curcumin. Indian J Exp Biol 48:280-8.
14. Galeone C, Pelucchi C, Levi F, et al. (2006). Onion and garlic use and human cancer. Am J Clin Nutr 84:1027-32.
15. Hard GC, Iatropoulos MJ, Jordan K, et al. (1993). Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res 53:4534-41.
16. Hasan N, Yusuf N, Toossi Z, Islam N. (2006). Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF-Alpha mRNA expression in human monocytes by allicin. FEBS Lett 580:2517-22.
17. Hirsch K, Danilenko M, Giat J, et al. (2000). Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 38:245-54.
18. Jakubikova J, Sedlak J. (2006). Garlic-derived organosulfides induce cytotoxicity, apoptosis, cell cycle arrest and oxidative stress in human colon carcinoma cell lines. Neoplasma 53:191-9.
19. Jordan VC. (2003). Tamoxifen: A most unlikely pioneering medicine. Natl Rev Drug Discov 2:205-13.
20. Kakkar R, Mantha S, Radhi J, et al. (1997). Antioxidant defense system in diabetic kidney: A time course study. Life Sci 60:667-79.
21. Labbe G, Pessayre D, Fromenty B. (2008). Drug-induced liver injury through mitochondrial dysfunction: Mechanisms and detection during preclinical safety studies. Fundam Clin Pharmacol 22:335-53.
22. Lee CP, Shih PH, Hsu CL, Yen GC. (2007). Hepatoprotection of tea seed oil (Camellia oleifera Abel) against CCl4-induced oxidative damage in rats. Food Chem Toxicol 45:888-95.
23. Liu Z, Shi HY, Nawaz Z, Zhang M. (2004). Tamoxifen induces the expression of maspin through estrogen receptor alpha. Cancer Lett 209:55-65.
24. Marklund SL. (1985). Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat Res 148:129-34.
25. Oge A, Sezer ED, Ozgonul M, et al. (2003). The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovarictomized rats. Neuroscience 338:217-20.
26. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-8.
27. Padilla-Camberos E, Zaitseva G, Padilla C, Puebla AM. (2010). Antitumoral activity of allicin in murine lymphoma L5178Y. Asian Pac J Cancer Prev 11:1241-4.
28. Patya M, Zahalka M, Vanichkin A, et al. (2004). Allicin stimulates lymphocytes and elicits an antitumor effect: A possible role of p21ras. Int Immunol 16:275-81.
29. Pedroso LS, Favero GM, de Camargo LE, et al. (2013). Effect of the o-methyl catechols apocynin, curcumin and vanillin on the cytotoxicity activity of tamoxifen. J Enzyme Inhib Med Chem 28:734-40.
30. Raja Naresh RA, Ndupa N, Uma Devi P. (1996). Effect of macrophage activation on niosome encapsulated bleomycin in tumor-bearing mice. Ind J Pharamcol 28:175-80.
31. Rivlin RS. (2001). Historical perspective on the use of garlic. J Nutr 131: 951-4S.
32. Schirner M, Hoffmann J, Menrad A, Schneider MR. (1998). Antiangiogenic chemotherapeutic agents: Characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res 4:1331-6.
33. Su QS, Tian Y, Zhang JG, Zhang H. (2008). Effects of allicin supplementation on plasma markers of exercise-induced muscle damage, IL-6 and antioxidant capacity. Eur J Appl Physiol 103: 275-83.
34. Tattelman E. (2005). Health effects of garlic. Am Fam Phys 72:103-6.
35. Weisenthal LM, Dill PL, Kunick NB, Lippman ME. (1983). Comparison of dye exclusion assays with a cologenic assay in the determination of drug-induced cytotoxicity. Cancer Res 43:258-64.